These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2596408

  • 21. Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes.
    Kodama I, Honjo H, Kamiya K, Toyama J.
    J Mol Cell Cardiol; 1990 Jan; 22(1):1-12. PubMed ID: 2157851
    [Abstract] [Full Text] [Related]

  • 22. Sodium channel states control binding and unbinding behaviour of antiarrhythmic drugs in cardiac myocytes from the guinea pig.
    Koumi S, Sato R, Katori R, Hisatome I, Nagasawa K, Hayakawa H.
    Cardiovasc Res; 1992 Dec; 26(12):1199-205. PubMed ID: 1337728
    [Abstract] [Full Text] [Related]

  • 23. Electrophysiological properties of the propafenone-analogue GE 68 (1-[3-(phenylethyl)-2-benzofuryl]-2-(propylamino)-ethanol) in isolated preparations and ventricular myocytes of guinea-pig hearts.
    Lemmens-Gruber R, Marei H, Heistracher P.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):230-8. PubMed ID: 9050017
    [Abstract] [Full Text] [Related]

  • 24. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T, Kodama I, Toyama J, Hayashi H, Saito H, Yamada K.
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [Abstract] [Full Text] [Related]

  • 25. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T.
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
    [Abstract] [Full Text] [Related]

  • 26. Effect of disopyramide on potassium currents in rabbit ventricular myocytes.
    Virág L, Varró A, Papp JG.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):268-75. PubMed ID: 9550298
    [Abstract] [Full Text] [Related]

  • 27. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H, Tohse N, Takeda Y, Kanno M.
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [Abstract] [Full Text] [Related]

  • 28. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.
    Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):662-73. PubMed ID: 1775199
    [Abstract] [Full Text] [Related]

  • 29. Electrophysiological effects of AN-132, a new antiarrhythmic compound, in guinea pig papillary muscles.
    Imanishi S, Morita S, Arita M.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):476-84. PubMed ID: 1691373
    [Abstract] [Full Text] [Related]

  • 30. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ, Su MJ, Kuo SC, Lin TP, Lee YS.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue.
    Damiano BP, Brannan MD.
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397
    [Abstract] [Full Text] [Related]

  • 32. [Electrophysiological effects of bunaftine, an antiarrhythmic drug, on action potential characteristics in ventricular muscle preparations].
    Kimura T, Nakazawa M, Imai S.
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):1-7. PubMed ID: 3093338
    [Abstract] [Full Text] [Related]

  • 33. Disopyramide phosphate: is it just another quinidine.
    Kus T, Sasyniuk BI.
    Can J Physiol Pharmacol; 1978 Apr; 56(2):326-31. PubMed ID: 638888
    [Abstract] [Full Text] [Related]

  • 34. Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle.
    Delpón E, Valenzuela C, Tamargo J.
    Br J Pharmacol; 1989 Apr; 96(4):970-6. PubMed ID: 2743087
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig.
    Inomata N, Ishihara T, Akaike N.
    Br J Pharmacol; 1991 Dec; 104(4):1007-11. PubMed ID: 1810589
    [Abstract] [Full Text] [Related]

  • 36. Electrophysiological and mechanical effects of caffeic acid phenethyl ester, a novel cardioprotective agent with antiarrhythmic activity, in guinea-pig heart.
    Chang GJ, Chang CJ, Chen WJ, Yeh YH, Lee HY.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):194-207. PubMed ID: 23396228
    [Abstract] [Full Text] [Related]

  • 37. Effects of combined use of class I antiarrhythmic agents on Vmax of guinea-pig ventricular muscles.
    Toyama J, Kawamura T, Kodama I.
    Cardiovasc Drugs Ther; 1991 Aug 28; 5 Suppl 4():801-4. PubMed ID: 1931757
    [Abstract] [Full Text] [Related]

  • 38. Block of cardiac sodium channels by antiarrhythmic drugs.
    Kodama I, Toyama J.
    Jpn Circ J; 1988 Mar 28; 52(3):231-7. PubMed ID: 2453687
    [Abstract] [Full Text] [Related]

  • 39. Effects of HNS-32, a novel antiarrhythmic agent, on guinea-pig myocardium.
    Noguchi K, Kase J, Saitoh M, Masumiya H, Saitoh M, Nakazawa T, Tanaka Y, Tanaka H, Hashimoto K, Shigenobu K.
    Pharmacology; 2002 Jan 28; 64(1):36-42. PubMed ID: 11731720
    [Abstract] [Full Text] [Related]

  • 40. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles.
    Pérez O, Valenzuela C, Delpón E, Tamargo J.
    Br J Pharmacol; 1997 Jan 28; 120(2):187-92. PubMed ID: 9117108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.